Emerald Advisers’s Immunomedics Inc IMMU Stock Holding History

Emerald Advisers’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23,234	Closed	-$823K	–	371
2020 Q2	$823K	Buy	+23,234	New	+$679K	0.04%	156

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Emerald Advisers's IMMU Position: Q3 2020 in Review

Emerald Advisers sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 23,234 shares — an estimated $823K sold.

Emerald Advisers first reported a position in IMMU in Q2 2020 and held it in 1 quarter. The position peaked at $823K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

Emerald Advisers reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
Emerald Advisers sold 23,234 Immunomedics Inc shares in Q3 2020, an estimated $823K.
Emerald Advisers first reported a position in Immunomedics Inc in Q2 2020 and held it in 1 quarter.
Emerald Advisers's Immunomedics Inc position peaked at $823K in Q2 2020.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Emerald Advisers's 13F filing for Q3 2020, filed 28 Oct 2020.